Gain Therapeutics Sets Sight on Investor Events
Oct 3, 2024
Biotechnology Invest Advisor
Gain Therapeutics Announces Webinar on GT-02287, a Promising Therapy for Parkinson's Disease
Sep 26, 2024
Vigil Neuroscience Receives Green Light from FDA for VG-3927 Clinical Trial
Sep 18, 2024
Recursion Pharmaceuticals Strengthens Position by Merging with Exscientia
Aug 19, 2024
Bionomics Advances BNC210 for PTSD after Positive FDA Phase 2 Meeting
Jul 31, 2024
Anavex Life Sciences Reports Promising Blarcamesine Results for Alzheimer's at AAIC
Jul 29, 2024
Longeveron Finalizes $9 Million Registered Direct Offering in Accordance with NASDAQ
Jul 19, 2024
Intelligent Bio Solutions Inc. Reports Biocompatibility Study Breakthrough in FDA 510(k) Submission Process
Jul 19, 2024
TuHURA Biosciences Acquires Exclusive Rights for Kineta, Inc.'s Novel Anti-VISTA Inhibitor
Jul 9, 2024
Gain Therapeutics Unveils Promising Data for GT-02287 at FENS Forum 2024
Jun 28, 2024
Investment Alert: Faruqi & Faruqi, LLP Examines Claims for Investors of Gritstone
Jun 23, 2024
Molecular Partners AG Unveils Promising Preclinical Results for Innovative Switch-DARPin Therapy at EHA 2024
Jun 15, 2024
Dyne Therapeutics Unveils Promising Preclinical FSHD Data from FORCE™ Platform
Jun 14, 2024
Faruqi & Faruqi, LLP Pursues Investor Claims Against Bluebird Bio Inc. BLUE
May 25, 2024
Senti Bio Advances Cancer Therapy with First Patient Dosed in SENTI-202 Phase 1 Trial
May 14, 2024
IMUNON Announces Q1 2024 Financial Performance and Business Progress
May 13, 2024
Cingulate Advances in ADHD Treatment Options, Seeks FDA New Drug Application
May 8, 2024
Gain Therapeutics Announces Participation in Public Ventures Discovery Day
Mar 16, 2024
The Implications of Alabama's Embryo Ruling on Investment Strategies
Mar 6, 2024
BioNTech and Autolus Forge CAR-T Therapy Collaboration Poised to Bolster Pipeline and Expand Late-Stage Programs
Feb 9, 2024
XtalPi Introduces Ailux: Pioneering the Future of AI-Enhanced Biologics Discovery
Jan 31, 2024
Danaher (DHR) Braces for Q4 Earnings Amid Biotechnology and Diagnostics Softness
Jan 27, 2024
Clinical Trials Outsourcing Set to Reach USD 74.38 Billion by 2031, Exhibiting a CAGR of 6.91%
Jan 15, 2024
BEAM Therapeutics' Stock Soars with Advancements in Sickle Cell Disease Therapy and Cost Reduction Strategies
Jan 4, 2024
Athira Pharma Showcases Preclinical Data of Fosgonimeton: A Potential Defense Against Alzheimer's Disease Pathology
Nov 16, 2023